Alzheimer's News -- ScienceDaily
1 day ago · Learn about Alzheimer's Disease symptoms such as memory loss and senile dementia. Find out about the treatments and causes, as well as the stages of Alzheimer's Disease and dementia.
Researchers have found a protein that seems to protect brain cells …
Jul 24, 2024 · A study of 48 post-mortem brains found a protein that appears to protect brain cells from Alzheimer's — even in people who had significant amounts of amyloid plaques in their brains.
FDA approves a second Alzheimer's drug, Eli Lilly's Kisunla - AP News
WASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
Centiloid guidelines and recommendations released for clinical …
3 days ago · The members of the Amyloid imaging to prevent Alzheimer's disease (AMYPAD) have announced the publication of a perspective review on the interpretability and clinical application of the Centiloid ...
Start of new era for Alzheimer’s treatment — Harvard Gazette
Jun 5, 2023 · Researchers say we appear to be at the start of a new era for Alzheimer’s treatment. Trial results published in January showed that for the first time a drug has been able to slow the cognitive decline characteristic of the disease.
With new therapies that promise to slow Alzheimer’s disease ... - CNN
Jul 16, 2023 · Under new draft guidelines for the diagnosis of Alzheimer’s disease, unveiled on Sunday at a large international gathering of physicians and researchers, these memory tests would take a...
First Alzheimer’s drug to slow disease progression gets full FDA ...
Jul 7, 2023 · The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.
News | Alzheimer's Association
Oct 28, 2024 · News updates for Alzheimer's and related dementias – find the latest information on treatments, care, research and Alzheimer's Association events.
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
Jul 6, 2023 · In studies reviewed by the FDA, Leqembi appeared to slow declines in memory and thinking by about 27% after 18 months of treatment. It also dramatically reduced the sticky beta-amyloid plaques...
Alzheimer's scientists say brain stimulating device could ... - NBC News
In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain network that stores memories and is typically hard hit by the disease.